Healthy, Immunized Communities Study
A Randomized Study to Determine the Efficacy of a Multi-tiered Community- and School-based Approach to Enhance School-aged Children's Recommended Vaccinations.
1 other identifier
interventional
148
1 country
1
Brief Summary
This project aims to understand how improving vaccine education and awareness can impact the number of parents who vaccinate, or intend to vaccine, their middle school-aged children with age-appropriate vaccines, including human papillomavirus (HPV), meningitis (MCV) and tetanus, diphtheria, pertussis (TDap).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 14, 2019
CompletedFirst Submitted
Initial submission to the registry
February 20, 2019
CompletedFirst Posted
Study publicly available on registry
February 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 9, 2023
CompletedResults Posted
Study results publicly available
July 12, 2024
CompletedJuly 12, 2024
January 1, 2024
1 year
February 20, 2019
March 18, 2023
January 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)
Parental intent to vaccinate their adolescent child with Tdap, MCV, and HPV vaccines, was dichotomized for each vaccine in the survey. Tdap and MCV included the options 1) intention to vaccinate/vaccinated ("plan to get this shot before the first day of 7th grade" or "up-to-date with this shot") or 2) no intention to vaccinate ("no plans to get this shot" or "have or plan to submit an exemption for this shot"). The HPV variable excluded the option "have or plan to submit an exemption for this shot" as vaccine is not required for school entry. Variables (Tdap, MCV, HPV) were compared within and between treatment groups from baseline to 6 mo. follow up with a generalized estimating equations model using the framework of a log-binomial logistic regression model. Risk ratios resulting from these models were used to quantify the magnitude and direction of any significant differences.
Participants were assessed at baseline and follow-up at 6 months.
Study Arms (2)
Usual Care
NO INTERVENTIONEducational emails about broad health topics to keep control group engaged
Multi-Component Intervention
ACTIVE COMPARATOR(1) a community event to raise parental awareness of the importance of vaccination; (2) social marketing to target parents' attitudes and knowledge around vaccinations in the form of educational material
Interventions
Formative focus group data was used to design an educational community event to improve information share and vaccine education/knowledge.
Formative focus group data was used to design educational messaging to be electronically distributed to intervention participants
Eligibility Criteria
You may qualify if:
- years or older
- Parents and guardians of children who attend a School District of Lancaster middle schools
- Individuals who read and understand English
- Individuals with an email address
You may not qualify if:
- Individuals who are non-English speaking
- Parents/Guardians \<18 years or older who do not have children attending a middle school in the School District of Lancaster
- Individuals who do not have an email address
- Individuals who plan on moving out of the Lancaster City area in the next year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Milton S. Hershey Medical Centerlead
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
Penn State College of Medicine
Hershey, Pennsylvania, 17033, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
We experienced low parent participation in the intervention activities, potentially limiting the effectiveness of the intervention and resulting outcomes.
Results Point of Contact
- Title
- Dr. Jennifer Kraschnewski, Professor of Medicine and Public Health Sciences
- Organization
- Penn State College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Kraschnewski
Penn State College of Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Following collection of baseline data, schools will be randomized. Study staff measuring the primary outcome will be blinded to school group assignment. Given the intervention, it is not possible to blind participants to group assignment.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 20, 2019
First Posted
February 26, 2019
Study Start
February 14, 2019
Primary Completion
February 28, 2020
Study Completion
February 9, 2023
Last Updated
July 12, 2024
Results First Posted
July 12, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
The following steps will be taken to protect subjects' privacy interests: identification and recruitment of potential subjects follows procedures consistent with privacy standards; consent discussion and research interventions will take place in a private setting; the information being collected will be limited to only the minimum amount of data necessary to accomplish the research purposes; the people with access to the identifiable research data will be limited to the minimum necessary as specified in the application and consent process. To external researchers or sponsors, data will be sent sent/received in aggregate/metrics (just counts, no individual data).